Prevalence and metabolic determinants of abnormal alanine aminotransferase: A cross-sectional study of Iranian adults, 2018–2022,Journal of Clinical Laboratory Analysis

当前位置： X-MOL 学术 › J. Clin. Lab. Anal. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prevalence and metabolic determinants of abnormal alanine aminotransferase: A cross-sectional study of Iranian adults, 2018–2022
Journal of Clinical Laboratory Analysis ( IF 2.6 ) Pub Date : 2023-07-05 , DOI: 10.1002/jcla.24937
Samaneh Asgari ₁ , Danial Molavizadeh ₂ , Maryam Tohidi ₁ , Amir Abbas Momenan ₁ , Fereidoun Azizi ₃ , Farzad Hadaegh ₁

Affiliation

Alanine aminotransferase (ALT) is an enzyme whose activity became the principal biomarker for liver disease. In the current study, we aimed to determine the prevalence of abnormal ALT, as a surrogate of nonalcoholic fatty liver disease (NAFLD) and its associated determinants using different criteria among Tehranian subjects between 2018 and 2022.

中文翻译：

丙氨酸氨基转移酶异常的患病率和代谢决定因素：2018-2022 年伊朗成年人的横断面研究

丙氨酸氨基转移酶 (ALT) 是一种酶，其活性成为肝病的主要生物标志物。在当前的研究中，我们旨在确定 2018 年至 2022 年间德黑兰受试者中作为非酒精性脂肪性肝病 (NAFLD) 替代指标的异常 ALT 的患病率及其相关决定因素，使用不同的标准。

更新日期：2023-07-05

点击分享查看原文

点击收藏

公开下载

阅读更多本刊新发论文本刊介绍/投稿指南